UK Private Healthcare Market size expected to reach USD 13.8 billion by 2026, at a CAGR of 2.6% during 2021 to 2027. The report gives a comprehensive outlook on private healthcare services in U.K with emphasis special emphasis on the role of NHS and PMI. The rise in the waiting list in recent times for several ailments in NHS is prompting patients to choose private healthcare services over NHS services. The rise in NHS waiting time more than 18 weeks for treatment is expected to bolster private healthcare market in the UK. Moreover, flexibility in GP referrals where, patients can opt for desired time, date, and hospital/clinic for consultation, which is creating a market opportunity for the players in U.K private healthcare market. According to NHS, the numbers of patients waiting for NHS services are growing in recent times. The decline in private medical insurance uptake in last few years and decreasing pay-out to clinics and hospitals for healthcare services by insurance providers expected to hinder market revenue growth in the midterm. Moreover, ongoing decline in inpatient and day caseload is currently hindering the market growth and relatively fewer companies offer medical benefits after retirement which could hinder market revenue growth of private healthcare market in U.K. The report studies U.K private healthcare market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, U.K private healthcare market report includes, number GP referrals in 2016, pricing analysis of major services, service provider share analysis and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the countries (Investment Hot-Spots) and market unmet needs (Service Opportunities).